Hygeia Therapeutics ^Company

Hygeia Therapeutics, Inc. acquires and develops biodegradable hormone-receptor modulators for topical indications. Its products include HYG-102, an estrogenic candidate for the topical treatment of age-related skin fragility and vaginal atrophy; HYG-440, an anti-androgenic candidate for the topical treatment of acne, hirsutism, and androgenic alopecia; and HYG-102440, the combination of HYG-102 and HYG-440 for the topical treatment of hair loss due to excess androgen activity in the scalp. The company was formerly known as Orcas Therapeutics, Inc. and changed its name to Hygeia Therapeutics, Inc. in December 2007. Hygeia Therapeutics was incorporated in 2005 and is based in Holden, Massachusetts.